Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Cellular and Molecular Biology

Pro-life (Fas/FasL) and Pro-death (HGF/c-Met) receptor/ligand system interactions regulates invasion in vitro.

Snezana Ivanova, Peter McCullough, Rachel Fung, David Peck and Ara Darzi
Snezana Ivanova
Imperial College, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter McCullough
Imperial College, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rachel Fung
Imperial College, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Peck
Imperial College, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ara Darzi
Imperial College, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published May 2007
  • Article
  • Info & Metrics
Loading
AACR Annual Meeting-- Apr 14-18, 2007; Los Angeles, CA

Abstract

2077

Introduction: Tumor metastasis is the limiting factor in successful treatment for a wide range of malignancies. Selective targeting of individual molecular pathways provides partial treatment benefit.

The Fas/ FasL system, widely investigated for its pro-apoptotic effects, has been indicated to correlate with tumor progression. Hepatocyte growth factor (HGF) through its receptor c-Met has been shown to enhance the invasive capacity of cancer cells via tyrosine kinase-dependent intracellular signalling pathways. The authors hypothesize that cross-talk between these two receptor/ligand systems and their signalling pathways can regulate proteases essential for tumor invasion and augment metastatic potential.

Methods: A human pancreatic ( PSN-1) and colon cancer (SW1222/ SW620) cancer cell lines were used. Quantitative analysis for presence of Fas/FasL and c-Met by Flow cytometry and qualitative images by fluorescence cytology were obtained. Assays were repeated in response to HGF, TNF-α, IL-6 and IL-8. Inhibition of signaling pathways was investigated by incorporating the potent tyrosine kinase inhibitors Wortmannin and Ly 294002. Fas and c-Met expression in response to Fas ligation was also determined by flow cytometry. HGF production in response to Fas ligation and the pro-inflamatory cytokines was determined by ELISA. Cell supernatants from control and CH-11/HGF treated cells were subjected to substrate zymography for MMP-2/MMP-9 expression. Densitometric analysis was done by Scion image software. The ability of CH-11 treated cells to invade through matrigel treated 8.0μm Transwell filters was analyzed by colorimetric MTS assay and by direct staining of the filters. Transcription factor Nf-kappaB and AP-1,activation was detected by EMSA. ANOVA analysis of variance was the statistical method employed.

Results: Fas and c-Met were constitutively expressed in all cell lines as detected by FACS and confirmed by Fluorescence microscopy. Whilst c-Met was upregulated Fas expression was downregulated in response to cytokines. HGF induced an autocrine upregulation of c-Met. Tyrosine kinase blockade attenuated that response. Protease production in response to HGF and Fas-L was enhanced. The stimulation of Fas with agonist resulted in: Significant dose dependent upregulation (p<0.05) of MMP2/MMP-9; Activation of transcription factors Nf-kappaB and Ap-1; and increased invasiveness.

Conclusions: Our results provide evidence that the invasive capacity of the HGF/c-Met system is strongly influenced by Fas/Fas-L. We have shown a clear interaction between the two receptor/ ligand systems

that may be critical in determining the metastatic potential of a range of gastrointestinal carcinomas. Further research in this direction may identify appropriate therapeutic targets.

#

Footnotes

  • 98th AACR Annual Meeting-- Apr 14-18, 2007; Los Angeles, CA

  • American Association for Cancer Research
Previous
Back to top
Cancer Research: 67 (9 Supplement)
May 2007
Volume 67, Issue 9 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Pro-life (Fas/FasL) and Pro-death (HGF/c-Met) receptor/ligand system interactions regulates invasion in vitro.
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Pro-life (Fas/FasL) and Pro-death (HGF/c-Met) receptor/ligand system interactions regulates invasion in vitro.
Snezana Ivanova, Peter McCullough, Rachel Fung, David Peck and Ara Darzi
Cancer Res May 1 2007 (67) (9 Supplement) 2077;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Pro-life (Fas/FasL) and Pro-death (HGF/c-Met) receptor/ligand system interactions regulates invasion in vitro.
Snezana Ivanova, Peter McCullough, Rachel Fung, David Peck and Ara Darzi
Cancer Res May 1 2007 (67) (9 Supplement) 2077;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Cellular and Molecular Biology

  • Abstract SY29-01: Functions of wild type and mutant p53
  • Abstract SY34-02: The impact of O2 availability on human cancer
  • Abstract SY19-01: Cell to cell variability in the responses of tumor cells to death ligands
Show more 3

Receptor-Mediated Signaling 2: Poster Presentations

  • Inverse TGF-beta signaling between host and tumor induced by omega-3 and omega-6 fatty acids in COLO205
  • Active c-Met signaling contributes to enhanced metastatic potential of nasopharyngeal carcinoma (NPC)
  • Neutralizing antibody against FGFR3 shows anti-tumor effects in multiple tumor models in vivo
Show more 3
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement